ストックスクリーナーアプリを入手
1.21
28.49%
0.2679
前日終値:
$0.9421
開ける：
$0.96
24時間の取引高:
338.34K
Relative Volume:
3.16
時価総額：
$41.25M
収益：
-
当期純損益:
$-14.47M
株価収益率:
-0.9758
EPS:
-1.24
ネットキャッシュフロー:
$-12.19M
1週間 パフォーマンス:
+21.41%
1か月 パフォーマンス:
-2.38%
6か月 パフォーマンス:
-45.96%
1年 パフォーマンス:
-45.72%
1日の値動き範囲:
$0.94
$1.31
1週間の範囲:
$0.9101
$1.31
52週間の値動き範囲:
$0.9101
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
BEAT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.22 | 33.13M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
275.13 | 46.10B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.96 | 10.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
61.88 | 12.48B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.99 | 8.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.79 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-09-11 | 開始されました | Needham | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Neutral |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-08-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-07-26 | 繰り返されました | Lake Street | Buy |
| 2018-04-26 | 繰り返されました | The Benchmark Company | Buy |
| 2018-02-23 | 繰り返されました | Dougherty & Company | Buy |
| 2017-11-08 | 繰り返されました | Dougherty & Company | Buy |
| 2017-10-26 | 開始されました | Raymond James | Outperform |
| 2017-10-24 | 開始されました | SunTrust | Buy |
| 2017-08-09 | 繰り返されました | Dougherty & Company | Buy |
| 2017-07-19 | 繰り返されました | The Benchmark Company | Buy |
| 2017-04-11 | 繰り返されました | Dougherty & Company | Buy |
| 2016-12-02 | 開始されました | Dougherty & Company | Buy |
| 2016-09-13 | 開始されました | Sidoti | Buy |
| 2016-08-03 | 繰り返されました | The Benchmark Company | Buy |
| 2015-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2013-10-24 | 開始されました | The Benchmark Company | Buy |
| 2013-08-21 | 開始されました | Dougherty & Company | Buy |
すべてを表示
Heartbeam Inc (BEAT) 最新ニュース
What indicators show strength in HeartBeam Inc.Free Early Entry Tips With Low Risk Zone - Newser
Pattern Scan Adds HeartBeam Inc. to WatchlistTrade Setups With Clear Risk Limits Highlighted - 선데이타임즈
Risk adjusted return profile for HeartBeam Inc. Equity Warrant analyzedEntry Timing Tracker with Alert Accuracy - Newser
What earnings revisions data tells us about HeartBeam Inc.Stock Market Trend and Pattern Analysis - Newser
HeartBeam Inc.’s volatility index tracking explainedFree Low Risk Swing Trade Opportunity List - Newser
Developing predictive dashboards with HeartBeam Inc. dataSwing Trade Planning with Consistent Setup - Newser
Why HeartBeam Inc. Equity Warrant stock attracts strong analyst attentionBuy Opportunity Forecast for Fast Traders - Newser
HeartBeam Inc. Equity Warrant stock trend outlook and recovery pathFree Quick Gain Stock Watch With Indicators - Newser
Will HeartBeam Inc. outperform small cap indexesMega Return Stock Alerts - mustnews.co.kr
Why HeartBeam Inc. stock attracts strong analyst attentionFundamental Analysis for Value Stock Selection - Newser
Earnings visualization tools for HeartBeam Inc. Equity WarrantAccurate Forecast System with AI Support - Newser
Is HeartBeam Inc. stock entering bullish territoryLong-Term Safety Investment Analysis Report - Newser
Is HeartBeam Inc. Equity Warrant still worth holding after the dipRisk-Managed Trade Alerts for Consistency - Newser
Will HeartBeam Inc. Equity Warrant rebound enough to break evenFree Early Breakout Entry Point Notifications - Newser
Is HeartBeam Inc. Equity Warrant meeting your algorithmic filter criteriaBreakout Screener With Alert Based Timing - Newser
Should you wait for a breakout in HeartBeam Inc.Buy and Exit Strategy Based on Momentum - Newser
How to track smart money flows in HeartBeam Inc.Equity Signal Recap With Long-Term Summary - Newser
Applying chart zones and confluence areas to HeartBeam Inc.Volatility Analysis and Entry Risk Mapping - Newser
Analyzing drawdowns of HeartBeam Inc. with statistical toolsAnnual Market Behavior and Sector Summary - Newser
Should you hold or exit HeartBeam Inc. nowDeep Learning Stock Forecast for Investors - Newser
Analyzing recovery setups for HeartBeam Inc. Equity Warrant investorsMomentum-Based Prediction for Quick Returns - Newser
Reversal indicators forming on HeartBeam Inc. stockDownside Control Plan With Support Analysis - Newser
What’s next for HeartBeam Inc. Equity Warrant stock priceStock Market Watch with Smart Filters - Newser
What to do if you’re stuck in HeartBeam Inc.Technical Reversal Setup with Risk Limits - Newser
HeartBeam BEAT 2025Q2 Earnings Preview Upside Potential Driven by Innovative Product Launch - AInvest
HeartBeam WRT BEATW 2025Q2 Earnings Preview Upside Anticipated Amid Strategic Expansion - AInvest
Intraday pattern recognizer results for HeartBeam Inc. Equity WarrantMinimal Risk Growth Investment Opportunity Analysis - Newser
How to forecast HeartBeam Inc. trends using time seriesSummary of Reliable Long-Term Trade Models - Newser
Detecting price anomalies in HeartBeam Inc. with AIFree High Growth Low Risk Stock Selection - Newser
Can HeartBeam Inc. Equity Warrant hit a new high this monthMomentum Screener with Buy and Sell Areas - Newser
Is HeartBeam Inc. Equity Warrant stock bottoming outHigh Return Idea With Technical Filter - Newser
How HeartBeam Inc. stock performs during market volatilityChart Driven Opportunity Scanner with Alerts - Newser
Intrinsic Value of HeartBeam Inc. Stock: Is It Undervalued or OvervaluedLow Volatility Stock Analysis With Confidence - Newser
Is HeartBeam Inc. Equity Warrant a candidate for recovery playFast Entry Strategy with Price Prediction - Newser
HeartBeam (NASDAQ: BEAT) FDA-Cleared System Provides Momentum as Company Moves to Innovate Cardiac Care - Barchart.com
Published on: 2025-08-07 08:05:51 - beatles.ru
HeartBeam Inc.'s FDA-Cleared System Revolutionizes Cardiac Care with Portable Technology - citybuzz -
HeartBeam Receives Two Patents for Cardiac Diagnostic Technology - Diagnostic and Interventional Cardiology
Sectors Driving Future Growth for HeartBeam Inc. StockChart Driven Opportunity Scanner with Alerts - Newser
HeartBeam’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics - Barchart.com
What makes HeartBeam Inc. Equity Warrant stock price move sharplyRSI Divergence and Support Breakout Analysis - Newser
HeartBeam Inc. Ranks High in Smart Money TrackerLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Is HeartBeam Inc. Equity Warrant a good long term investmentDiscover high-impact stocks for your portfolio - Jammu Links News
When is HeartBeam Inc. stock expected to show significant growthNavigate market volatility with smart strategies - Jammu Links News
When is HeartBeam Inc. Equity Warrant stock expected to show significant growthFree Investment Community - Jammu Links News
What analysts say about HeartBeam Inc. stockBuild wealth faster with consistent investment plans - Jammu Links News
What institutional investors are buying HeartBeam Inc. Equity Warrant stockBuild a portfolio that stands the test of time - Jammu Links News
How strong is HeartBeam Inc. Equity Warrant company’s balance sheetDynamic investment growth - Jammu Links News
Is HeartBeam Inc. a good long term investmentBuild wealth with reliable stock picks - Jammu Links News
What are HeartBeam Inc. Equity Warrant company’s key revenue driversFree Stock Index Interpretation - Jammu Links News
How many analysts rate HeartBeam Inc. Equity Warrant as a “Buy”Market-leading capital gains - Jammu Links News
Heartbeam Inc (BEAT) 財務データ
収益
当期純利益
現金流量
EPS
Heartbeam Inc (BEAT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cruickshank Tim | CFO |
Feb 14 '25 |
Buy |
1.70 |
17,647 |
30,000 |
17,647 |
| de Urioste George | Director |
Sep 06 '24 |
Sale |
2.34 |
1,674 |
3,917 |
57,146 |
| de Urioste George | Director |
Aug 30 '24 |
Sale |
2.31 |
5,500 |
12,705 |
58,820 |
| de Urioste George | Director |
Aug 27 '24 |
Sale |
2.26 |
2,194 |
4,958 |
64,320 |
| de Urioste George | Director |
Aug 23 '24 |
Sale |
2.30 |
2,500 |
5,750 |
66,814 |
| de Urioste George | Director |
Aug 26 '24 |
Sale |
2.38 |
300 |
714 |
66,514 |
0.52%
1.57%
大文字化:
|
ボリューム (24 時間):